Aceragen, inc. to delist from the nasdaq stock market

Durham, n.c. and exton, pa., aug. 04, 2023 (globe newswire) -- aceragen, inc. (the “company”) (nasdaq: acgn), announced today that the company intends to voluntarily terminate the listing of its common stock on the nasdaq capital market (“nasdaq”) by filing a form 25 with the securities and exchange commission (the “sec”) on or about august 15, 2023. as previously disclosed, on august 14, 2023, the company expects to hold a special meeting seeking stockholder approval to effect a transfer and assignment of substantially all of the company's assets to an assignee for the benefit of creditors (the “assignment proposal”). subject to stockholder approval of the assignment proposal, and in order to ensure an orderly delisting process, the company has determined to voluntarily terminate the listing of its common stock on the nasdaq by filing a form 25 with the sec on or about august 15, 2023.
ACGN Ratings Summary
ACGN Quant Ranking